SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

PINTO, Louise L. C.  and  GRUPO DE ESTUDOS SOBRE MPS II et al. Avaliação prospectiva de 11 pacientes brasileiros com mucopolissacaridose II. J. Pediatr. (Rio J.) [online]. 2006, vol.82, n.4, pp.273-278. ISSN 0021-7557.

    1. Neufeld EF, Muenzer J. The mucopolysaccharidosis. In: Scriver CR, Beandet AL, Sly S, Valle D, Childs B, Kinzler KW, Volgesltein B, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill; 2001. p. 3421-52. [ Links ]

    2. Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet A. 2003;123:310-3. [ Links ]

    3. Online Mendelian Inheritance in Man (OMIM) [site na internet]. Baltimore: Johns Hopkins University. Acesso: 30/05/2006. [ Links ]

    4. Giugliani R, Schwartz I. MPS Brazil Network: an alternative approach to improve diagnosis of metabolic disorders in developing countries. J Metab Genet. 2006 (In Press). [ Links ]

    5. Muenzer J. Mucopolysaccharidoses. Adv Pediatr. 1986;33:269-302. [ Links ]

    6. Whitley CB. The mucopolysaccharidoses. In: Beighton P, editor. McKusick's Heritable Disorders of Connective Tissue. St Louis: Mosby; 1993. p. 367-498. [ Links ]

    7. Lonergan CL, Payne AR, Wilson WG, Patterson JW, English JC 3rd. What syndrome is this? Hunter Syndrome. Pediatr Dermatol. 2004;21:679-81. [ Links ]

    8. Albano LM, Sugayama SS, Bertola DR, Andrade CE, Utagawa CY, Puppi F, et al.. Clinical and laboratorial study of 19 cases of mucopolysaccharidoses. Rev Hosp Clin Fac Med Sao Paulo. 2000;55:213-8. [ Links ]

    9. Young ID, Harper PS. The natural history of the severe form of Hunter's syndrome: a study based on 52 cases. Dev Med Child Neurol. 1983;25:481-9. [ Links ]

    10. Young ID, Harper PS, Archer IM, Newcombe RG. A clinical and genetic study of Hunter's syndrome. 1. Heterogeneity. J Med Genet. 1982;19:401-7. [ Links ]

    11. Knoell KA, Tunnessen WW Jr. Picture of the month. Hunter syndrome (mucopolysaccharidosis IIA). Arch Pediatr Adolesc Med. 2000;154:85-6. [ Links ]

    12. Demitsu T, Kakurait M, Okubo Y, Shibayama C, Kikuchi Y, Mori Y, et al. Skin eruption as the presenting sign of Hunter syndrome IIB. Clin Exp Dermatol. 1999;24:179-82. [ Links ]

    13. Weinreb NJ, Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, et al. Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry. Am J Med. 2002;113:112-9. [ Links ]

    14. ATS Committee on proficiency standards for clinical pulmonary function laboratories. American Thoracic Society Statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-7. [ Links ]

    15. Nelhaus G. Head circumference from birth to eighteen years: practical composite international and interracial graphs. Pediatr. 1968;41:106-14. [ Links ]

    16. Motta MEFA, Silva GAP. Desnutrição e obesidade em crianças: delineamento do perfil de uma comunidade de baixa renda. J Pediatr (Rio J). 1977;4:288-293. [ Links ]

    17. Hamil PV, Drizd TA, Jonhson CL, Reed RB, Roche AF, Moore WM. Physical growth: National Center of Health Statistics percentiles. Am J Clin Nutr. 1979;32:607-29. [ Links ]

    18. World Health Organization. Physical status: the use and the interpretation of anthropometry. Tech Rep Ser 854. Geneva: WHO; 1995. [ Links ]

    19. Black MM, Matula K. Essentials of Bayley Scales of Infant Development II Assessment. New York: Wiley; 1999. [ Links ]

    20. Weschler D. WPPSI-R Manual Wechsler preschool and primary scale of intelligence-revised. New York: Psychological Corporation; 1989. [ Links ]

    21. Roid GH, Miller LJ. A totally non-verbal intelligence & cognitive abilities test. St. Louis: Stoelting; 2000. [ Links ]

    22. Schwartz IVD. Estudo clínico, bioquímico e genético de pacientes com mucopolissacaridose tipo II e de possíveis heterozigotas [dissertação]. Porto Alegre: Universidade Federal do Rio Grande do Sul; 2004. [ Links ]

    23. Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM,Muenzer J, et al. Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blind, placebocontrolled, multinational study of recombinant á-L-iduronidase (Laronidase). J Pediatr. 2004;144:581-8. [ Links ]

    24. Harmatz P, Ketteridge D, Giugliani R, Guffon N, Teles EL, Miranda MC, et al. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Pediatrics. 2005;115:e681-9. [ Links ]

    25. Solway S, Broocks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001;119:256-70. [ Links ]